Sanofi is set to classify Opella's business as discontinued operations following a transaction expected to close in Q2 2025, impacting its financial reporting. The company anticipates a low single-digit percentage growth in business EPS for 2024, excluding Opella, while maintaining its focus on shareholder returns and external growth opportunities. Sanofi continues to prioritize innovation in healthcare, aiming to enhance lives globally through scientific advancements.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
